Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

Kidney International
L-J MaAgnes B Fogo

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcriptional factors with beneficial effects in diabetes mediated by improved insulin sensitivity and lipid metabolism, but potential adverse effects in atherosclerosis by promoting in vitro foam cell formation. We explored whether a PPAR gamma agonist, troglitazone (TGL), affects sclerosis by mechanisms unrelated to insulin and lipid effects in a model of nondiabetic glomerulosclerosis. Adult male Sprague Dawley rats underwent 5/6 nephrectomy and were treated for 12 weeks as follows: control (CONT), no further treatment; triple antihypertensive therapy (TRX); and TGL or TGL + TRX. Functional, morphological, and molecular analyses were performed. Systolic blood pressure (SBP) was increased in CONT and TGL groups (161 +/- 1 and 160 +/- 3 mm Hg), but not in TGL + TRX and TRX (120 +/- 3 vs. 126 +/- 1 mm Hg, P < 0.0001 vs. non-TRX). Serum triglyceride and cholesterol levels in all groups remained normal except for slightly higher serum cholesterol levels in TRX group. TGL groups had reduced proteinuria, serum creatinine, and glomerulosclerosis versus CONT, in contrast to no significant effect with TRX...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SchneidermanD J Loskutoff
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Nov 3, 1989·Science·A B Pardee
Jul 1, 1988·The Journal of Clinical Investigation·A FogoI Ichikawa
Feb 1, 1987·The Journal of Clinical Investigation·C F Nathan
Sep 1, 1993·The Journal of Clinical Investigation·S FazioS C Rall
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Jun 1, 1996·Atherosclerosis·N NoguchiT Kodama
Oct 15, 1996·The Journal of Clinical Investigation·R E LawW A Hsueh
Dec 1, 1996·Current Opinion in Cell Biology·R P BrunB M Spiegelman
Apr 1, 1997·Genes & Development·J LaBaerE Harlow
Oct 27, 1998·Trends in Biochemical Sciences·J O Funk, D A Galloway
Oct 31, 1998·European Journal of Pharmacology·P E BealesP Pozzilli
Apr 24, 1999·Experimental Nephrology·A B Fogo

❮ Previous
Next ❯

Citations

Jul 25, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Agnes B Fogo
Aug 3, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Agnes B Fogo
Dec 1, 2005·Current Diabetes Reports·Yahua Zhang, Youfei Guan
Apr 26, 2012·Genes & Nutrition·Claudia Tovar-PalacioArmando R Tovar
Dec 29, 2009·Acta Pharmacologica Sinica·Rong ZouYing Yao
Aug 26, 2006·Nature Clinical Practice. Nephrology·Usha PanchapakesanCarol A Pollock
Jun 13, 2012·Nature Reviews. Nephrology·Larry A GreenbaumWilliam E Smoyer
Mar 29, 2002·Kidney International·Robert Earl RouthKevin John McCarthy
Mar 29, 2002·Kidney International·Brad H RovinTodd Hilbelink
May 25, 2002·Kidney International·Paisit PaueksakonAgnes B Fogo
Oct 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Monica P ReveloAgnes B Fogo
Apr 5, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gang Jee KoDae Ryong Cha
Jan 22, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jing XiaoKar Neng Lai
Apr 28, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Asish K GhoshJohn Varga
Feb 22, 2002·Current Opinion in Nephrology and Hypertension·Willa A Hsueh, Susanne B Nicholas
Apr 15, 2008·Current Opinion in Nephrology and Hypertension·Agnes B Fogo
Nov 13, 2007·Journal of Gastroenterology and Hepatology·Rupjyoti Talukdar, Rakesh K Tandon
Jan 18, 2008·Nephrology·Priscilla Kincaid-SmithJoseph Proietto
Dec 1, 2005·Kidney International·Xiong Z RuanJohn F Moorhead
Jun 26, 2007·Kidney & Blood Pressure Research·Bum Soon ChoiChul Woo Yang
Feb 15, 2011·American Journal of Respiratory and Critical Care Medicine·Manu JainGökhan M Mutlu
Jul 10, 2012·Disease Models & Mechanisms·Cristina Martínez-GarcíaGema Medina-Gomez
Aug 12, 2008·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Kazumi Hayashi
Jul 18, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tamehachi NamikoshiNaoki Kashihara
Jun 18, 2011·The Journal of Endocrinology·Victor P BilanStevan P Tofovic
Mar 14, 2008·Journal of the American Society of Nephrology : JASN·Aoife M WatersTino D Piscione
Oct 3, 2009·Journal of the American Society of Nephrology : JASN·Hai-Chun YangAgnes B Fogo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.